• Home
  • Category: Gastroenterology

Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: open-label extension of the NOR-SWITCH trial

NOR-SWITCH trial shows switching from infliximab originator to less expensive biosimilar CT-P13 was not inferior to continued treatment with inflixima...

Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study

Pediatric patients aged 4-17 years with newly diagnosed ulcerative colitis were recruited from 29 centers in the USA and Canada. The primary outcome w...

Quality of meta-analyses in major leading gastroenterology and hepatology journals: A systematic review

Country, a number of patients, funding sources were also revealed. Publication in recent years showed a significantly better methodological quality th...

Telemedicine and Mobile Health Technology Are Effective in the Management of Digestive Diseases: A Systematic Review

Mobile applications and interactive websites are an increasingly used method of telemedicine. This study aims to explore digestive disease studies tha...

Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review

Altering the gut microbiota has been proposed as a strategy for the treatment of IBS. Family Enterobacteriaceae (phylum Proteobacteria) and genus Bac...

Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review

Altering the gut microbiota has been proposed as a strategy for the treatment of IBS. Family Enterobacteriaceae (phylum Proteobacteria) and genus Bac...

Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia

The Asia-Pacific Working Group on Inflammatory Bowel Disease was established in Cebu, Philippines. It aims to improve inflammatory bowel disease care...

Rifaximin has gained popularity for this indication despite its use is not evidence based. It seems to be effective and safe for the treatment of SIBO.

Palm oil (PO) is used in infant formulas to achieve palmitic acid levels similar to those in human milk. PO is associated with harder stools and SN-2-...

Departments

Recent Posts